Identification of GPC3 mutation and upregulation in a multidrug resistant osteosarcoma and its spheroids as therapeutic target
Authors:
Open Access
- 20 September 2021
- journal article
- research article
- Published by Elsevier in Journal of Bone Oncology
- Vol. 30, 100391
Abstract
No abstract availableKeywords
Funding Information
- South China University of Technology
- National Key Research and Development Program of China (2016YFB0700803, 2017YFB0702604)
- National Natural Science Foundation of China (31771038, 81450016)
This publication has 66 references indexed in Scilit:
- Osteosarcoma: Evolution of Treatment ParadigmsSarcoma, 2013
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samplesNature Biotechnology, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Micro‐RNA profiles in osteosarcoma as a predictive tool for ifosfamide responseInternational Journal of Cancer, 2010
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009
- Osteosarcoma incidence and survival rates from 1973 to 2004Cancer, 2009
- International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly personsInternational Journal of Cancer, 2009
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986